ACM
NBSE

AIGH Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

AIGH Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,601
Closed -$345K – 58
2022
Q3 		$345K Sell
43,601
-7,778
-15% -$61.5K 0.11% 42
2022
Q2 		$1.08M Hold
51,379
– – 0.28% 34
2022
Q1 		$1.93M Buy
51,379
+1,365
+3% +$51.3K 0.47% 25
2021
Q4 		$2.81M Buy
+50,014
New +$2.81M 0.86% 27